Cargando…
Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures
Background: Off-pump coronary artery bypass grafting (OPCAB) is believed to limit inflammatory reaction. Neutrophil to lymphocyte ratio (NLR) is one of the more common and easily accessible markers of inflammatory response. The aim of the study was to compare postoperative results of NLR with mid-te...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482266/ https://www.ncbi.nlm.nih.gov/pubmed/34563003 http://dx.doi.org/10.3390/clinpract11030074 |
_version_ | 1784576867614851072 |
---|---|
author | Urbanowicz, Tomasz Michalak, Michał Gąsecka, Aleksandra Perek, Bartłomiej Rodzki, Michał Bociański, Michał Straburzyńska-Migaj, Ewa Jemielity, Marek |
author_facet | Urbanowicz, Tomasz Michalak, Michał Gąsecka, Aleksandra Perek, Bartłomiej Rodzki, Michał Bociański, Michał Straburzyńska-Migaj, Ewa Jemielity, Marek |
author_sort | Urbanowicz, Tomasz |
collection | PubMed |
description | Background: Off-pump coronary artery bypass grafting (OPCAB) is believed to limit inflammatory reaction. Neutrophil to lymphocyte ratio (NLR) is one of the more common and easily accessible markers of inflammatory response. The aim of the study was to compare postoperative results of NLR with mid-term OPCAB results. Methods: In total, 224 patients (198 (88%) men and 26 (12%) women) with mean age 65 +/− 9 years who underwent OPCAB though median full sternotomy in our department in 2018 enrolled into the study. We scrupulously collected the postoperative mid-term results, including survival rate, clinical status and risk for major adverse events, and compared them with perioperative laboratory results. Results: A three-year follow-up was completed by 198 individuals (90% survival rate) with 12 (5%) showing major adverse cardiovascular (MACE) events risk. In the multivariable analysis, the laboratory parameters noticed on the 1st postoperative day were statistically significantly predictive of survival, including neutrophils (HR 1.59, 1.33–1.89 95%CI, p < 0.0001), platelets (HR 1.01, 1.01–1.01 95%CI, p = 0.0065), NLR (HR 1.47, 1.3–1.65 95%CI, p < 0.0001) and postoperative ejection fraction (HR 0.9, 0.87–0.95 95%CI, p < 0.0001). Conclusions: Postoperative NLR above 4.6, as an inflammatory reaction marker, is related to mid-term mortality in OPCAB patients. |
format | Online Article Text |
id | pubmed-8482266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84822662021-10-01 Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures Urbanowicz, Tomasz Michalak, Michał Gąsecka, Aleksandra Perek, Bartłomiej Rodzki, Michał Bociański, Michał Straburzyńska-Migaj, Ewa Jemielity, Marek Clin Pract Article Background: Off-pump coronary artery bypass grafting (OPCAB) is believed to limit inflammatory reaction. Neutrophil to lymphocyte ratio (NLR) is one of the more common and easily accessible markers of inflammatory response. The aim of the study was to compare postoperative results of NLR with mid-term OPCAB results. Methods: In total, 224 patients (198 (88%) men and 26 (12%) women) with mean age 65 +/− 9 years who underwent OPCAB though median full sternotomy in our department in 2018 enrolled into the study. We scrupulously collected the postoperative mid-term results, including survival rate, clinical status and risk for major adverse events, and compared them with perioperative laboratory results. Results: A three-year follow-up was completed by 198 individuals (90% survival rate) with 12 (5%) showing major adverse cardiovascular (MACE) events risk. In the multivariable analysis, the laboratory parameters noticed on the 1st postoperative day were statistically significantly predictive of survival, including neutrophils (HR 1.59, 1.33–1.89 95%CI, p < 0.0001), platelets (HR 1.01, 1.01–1.01 95%CI, p = 0.0065), NLR (HR 1.47, 1.3–1.65 95%CI, p < 0.0001) and postoperative ejection fraction (HR 0.9, 0.87–0.95 95%CI, p < 0.0001). Conclusions: Postoperative NLR above 4.6, as an inflammatory reaction marker, is related to mid-term mortality in OPCAB patients. MDPI 2021-09-03 /pmc/articles/PMC8482266/ /pubmed/34563003 http://dx.doi.org/10.3390/clinpract11030074 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Urbanowicz, Tomasz Michalak, Michał Gąsecka, Aleksandra Perek, Bartłomiej Rodzki, Michał Bociański, Michał Straburzyńska-Migaj, Ewa Jemielity, Marek Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title | Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title_full | Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title_fullStr | Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title_full_unstemmed | Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title_short | Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures |
title_sort | postoperative neutrophil to lymphocyte ratio as an overall mortality midterm prognostic factor following opcab procedures |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482266/ https://www.ncbi.nlm.nih.gov/pubmed/34563003 http://dx.doi.org/10.3390/clinpract11030074 |
work_keys_str_mv | AT urbanowicztomasz postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT michalakmichał postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT gaseckaaleksandra postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT perekbartłomiej postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT rodzkimichał postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT bocianskimichał postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT straburzynskamigajewa postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures AT jemielitymarek postoperativeneutrophiltolymphocyteratioasanoverallmortalitymidtermprognosticfactorfollowingopcabprocedures |